EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC 4.0

Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer

Daping Zhang, Adekemi Taylor, Jie Janet Zhao, Christopher J Endres, Ariel Topletz-Erickson iD

Clinical Pharmacokinetics · 2024

DOI: 10.1007/s40262-024-01412-0 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Clinical Pharmacokinetics, 2024. Verfasst von Daping Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc., 21717 30th Dr SE, Bothell, WA, 98021, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Colorectal Neoplasms, Models, Biological, Oxazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This study was sponsored by Seagen which was acquired by Pfizer in December 2023.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsColorectal NeoplasmsModels, BiologicalOxazolesPyridinesErb-b2 Receptor Tyrosine KinasesAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultHealthy VolunteersProtein Kinase InhibitorsQuinazolines

Substanzen

OxazolesProtein Kinase InhibitorsPyridinesQuinazolinesErb-b2 Receptor Tyrosine KinasesERBB2 protein, humantucatinib

Autor:innen und Institutionen

  • Pfizer Inc., 21717 30th Dr SE, Bothell, WA, 98021, USA.
  • Integrated Drug Development, Certara USA, Princeton, NJ, USA.
  • Immunome, Exton, PA, USA.
  • Pfizer Inc., 21717 30th Dr SE, Bothell, WA, 98021, USA. Ariel.Erickson@pfizer.com.

ORCID-Profile: Ariel Topletz-Erickson

Förderung

  • This study was sponsored by Seagen which was acquired by Pfizer in December 2023

Zitieren

APA

Zhang, D., Taylor, A., Zhao, J. J., Endres, C. J., & Topletz-Erickson, A. (2024). Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-024-01412-0

Vancouver

Zhang D, Taylor A, Zhao JJ, Endres CJ, Topletz-Erickson A. Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer. Clinical Pharmacokinetics. 2024. doi:10.1007/s40262-024-01412-0

BibTeX
@article{Zhang2024,
  author = {Zhang, Daping and Taylor, Adekemi and Zhao, Jie Janet and Endres, Christopher J and Topletz-Erickson, Ariel},
  title = {Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer},
  journal = {Clinical Pharmacokinetics},
  year = {2024},
  doi = {10.1007/s40262-024-01412-0}
}
Kostenlos starten →